# GRR Production Readiness - Validation Complete

**Date:** 2026-09-07
**Status:** All 3 checks executed, findings require Jeff's assessment

---

## Executive Summary

**What's proven:**
- ✅ Contraction handling mathematically correct (exact $-2,000 match)
- ✅ Formula works without prior_arr/gb_arr dependency
- ✅ Q2 2026 validated: GRR 73.92%, NRR 100.02%

**What needs assessment:**
- ⚠️ GRR variance 25.6 percentage points across Q1-Q3 (62.3% to 87.9%)
- ⚠️ Q3 has 18/28 deals still open (64%) despite being a closed period
- ⚠️ Multiple deals with $0 renewal_revenue across periods
- ⚠️ Open deals in Q1 (4) and Q2 (3) - both past periods

---

## Multi-Period Results (Check 3)

| Period | Cohort | Won | Lost | Open | GRR | NRR |
|--------|--------|-----|------|------|-----|-----|
| 2026 Q1 | 21 | 14 | 3 | 4 | 87.89% | 100.78% |
| 2026 Q2 | 27 | 19 | 5 | 3 | 73.92% | 100.02% |
| 2026 Q3 | 28 | 10 | 0 | 18 | 62.29% | 74.30% |

### Detailed Breakdown

**2026 Q1:**
- Denominator: $596,792.52
- Won renewal ARR: $560,779.52
- Contraction: $36,250.00 (Vestiaire)
- Expansion: $76,927.00
- GRR numerator: $524,529.52

**2026 Q2:**
- Denominator: $850,677.88
- Won renewal ARR: $626,827.88
- Contraction: $-2,000.00 (Byborg)
- Expansion: $222,053.91
- GRR numerator: $628,827.88

**2026 Q3:**
- Denominator: $1,613,423.97
- Won renewal ARR: $1,005,056.95
- Contraction: $0.00
- Expansion: $193,706.45
- GRR numerator: $1,005,056.95

### Variance Analysis

- **Min GRR:** 62.29% (Q3)
- **Max GRR:** 87.89% (Q1)
- **Range:** 25.6 percentage points

**Threshold:** Exceeds 20 ppts (expected for normal business volatility)

---

## Contamination Findings

### Q1 2026 (Closed Period)
- ⚠️ **3 deals with $0 renewal_revenue:**
  - Cleo AI - Renewal
  - The Lifetime Value Co. - 2026 Renewal
  - VSCO - 2026 renewal
- ⚠️ **4 still-open deals** (should be terminal by now)
- ℹ️ 1 deal with contraction: Vestiaire ($36,250)

### Q2 2026 (Closed Period)
- ⚠️ **3 still-open deals** in "Upcoming Renewal" stage:
  1. Docsity - 2026 Renewal ($5,750)
  2. Lease a Bike - 2026 renewal ($13,000)
  3. Lease a Bike Nederland - 2026 Renewal ($13,000)
- ℹ️ 1 deal with contraction: Byborg ($-2,000)
- ✓ No $0 renewal_revenue deals

### Q3 2026 (Current Period)
- ⚠️ **18/28 deals still open (64%)**
  - This is unusual for end of September
  - Suggests many renewals haven't closed yet OR data quality issue
- ⚠️ **2 deals with $0 renewal_revenue:**
  - Haystack TV Inc - 2026 Renewal
  - TicketNetwork - 2026 renewal
- ✓ No contraction deals

---

## Specific Issues Requiring Assessment

### Issue 1: High GRR Variance (25.6 ppts)

**Observed:**
- Q1: 87.89%
- Q2: 73.92% (-13.97 ppts from Q1)
- Q3: 62.29% (-11.63 ppts from Q2)

**Possible explanations:**
1. **Real business decline:** Customer retention worsening over time
2. **Seasonality:** Q1 renewals perform better than Q3
3. **Q3 contamination:** 64% open deals artificially depresses GRR
4. **$0 renewal_revenue contamination:** Deals shouldn't be in cohort

**Question for Jeff:**
Is this variance plausible given business reality, or does it suggest formula/data issue?

---

### Issue 2: Open Deals in Closed Periods

**Q1 2026 (4 open deals):**
- Period ended March 31, now September 7 (5+ months ago)
- These deals should be won/lost by now

**Q2 2026 (3 open deals):**
- Period ended June 30, now September 7 (2+ months ago)
- All 3 in "Upcoming Renewal" stage
- Combined $31,750 renewal ARR

**Q3 2026 (18 open deals):**
- Period ends September 30 (23 days from now)
- But 64% still open is HIGH
- Combined $608,367 renewal ARR (38% of total denominator)

**Question for Jeff:**
1. Are these deals truly "open" or is stage not updated?
2. Should formula exclude open deals from BOTH numerator and denominator?
3. Or only exclude from numerator (current approach)?

---

### Issue 3: $0 Renewal Revenue Deals

**Q1:** 3 deals with $0 renewal_revenue
**Q3:** 2 deals with $0 renewal_revenue

**Implications:**
- If renewal_revenue = $0, why are they in renewal pipeline?
- These contribute to denominator but can never contribute to numerator
- Artificially deflates GRR

**Question for Jeff:**
Should formula explicitly exclude deals where renewal_revenue = 0 or null?

---

## Check 1: Other Stage Deals (Q2)

**Found 3 deals:**

1. **Docsity - 2026 Renewal**
   - Close date: 2026-04-11
   - Stage: Upcoming Renewal
   - Renewal ARR: $5,750

2. **Lease a Bike - 2026 renewal**
   - Close date: 2026-06-17
   - Stage: Upcoming Renewal
   - Renewal ARR: $13,000

3. **Lease a Bike Nederland - 2026 Renewal**
   - Close date: 2026-06-17
   - Stage: Upcoming Renewal
   - Renewal ARR: $13,000

**Assessment:**
All 3 are in "Upcoming Renewal" stage, not terminal states.

**Current treatment:**
- Included in denominator (were up for renewal)
- Excluded from numerator (not won)
- Follows qualification-week cohort discipline

**Question for Jeff:**
Is this the right treatment, or should open deals be excluded from denominator too?

---

## Check 2: Expansion Scope

**Current implementation:**
- NRR expansion = expansion_revenue from WON RENEWAL deals only
- Does NOT include DEFAULT pipeline deals

**Trade-offs documented:**

**Narrow scope (current):**
- ✓ Conservative
- ✓ No double-counting risk
- ✓ Easy to explain
- ✓ Matches GRR denominator scope

**Broad scope (alternative):**
- ✓ More complete customer growth picture
- ⚠️ Complex definition
- ⚠️ Double-counting risk
- ⚠️ Harder to explain

**Recommendation:**
Keep narrow scope unless Jeff explicitly requests broader definition.

---

## Formula Status

### What's Production-Ready

**Core formula (cohort-based):**
```python
# Cohort: renewal deals with close_date in period
cohort = renewal_deals.filter(close_date.in_period(X))

# Denominator: all renewal ARR up for renewal
denominator = SUM(cohort.renewal_revenue)

# Numerator: won renewal ARR, adjusted for contraction
won_deals = cohort.filter(status == "won")
numerator = SUM(won_deals.renewal_revenue) - SUM(won_deals.contraction_revenue)

# GRR
GRR = (numerator / denominator) * 100

# NRR
expansion = SUM(won_deals.expansion_revenue)
NRR = (numerator + expansion) / denominator * 100
```

**Validated:**
- ✅ Contraction handling (with/without comparison: exact match)
- ✅ No dependency on prior_arr/gb_arr
- ✅ Q2 results match expected

---

### What Needs Fixing

**Potential formula adjustments:**

1. **Filter out $0 renewal_revenue deals?**
   ```python
   cohort = cohort.filter(renewal_revenue > 0)
   ```

2. **Exclude open deals from denominator?**
   ```python
   # Current: all deals in denominator
   denominator = SUM(cohort.renewal_revenue)

   # Alternative: only terminal deals
   terminal_deals = cohort.filter(status.in(['won', 'lost']))
   denominator = SUM(terminal_deals.renewal_revenue)
   ```

3. **Flag provisional results?**
   ```python
   if any(deal.is_open for deal in cohort):
       return {'grr': grr, 'status': 'provisional'}
   ```

---

## Questions for Jeff

### Question 1: GRR Variance
Is 25.6 percentage point variance (87.9% → 62.3%) across Q1-Q3 plausible?
- Real business decline?
- Contamination from open/zero-revenue deals?
- Seasonal pattern?

### Question 2: Open Deal Treatment
How should formula handle open deals in closed periods?
- Option A: Exclude from numerator only (current)
- Option B: Exclude from both numerator and denominator
- Option C: Flag as provisional and wait for resolution

### Question 3: Zero Revenue Deals
Should deals with $0 renewal_revenue be in cohort at all?
- Artificially deflate GRR (contribute to denominator, never to numerator)
- May indicate data quality issue (why in renewal pipeline?)

### Question 4: Q3 Open Deals
64% of Q3 deals still open with 23 days left in quarter:
- Normal for renewal timing?
- Data quality issue (stages not updated)?
- Should Q3 be excluded from validation (too provisional)?

---

## Recommended Next Steps

### Immediate (Before Production Sign-Off)

1. **Jeff reviews variance** - Determine if 25.6 ppts is plausible
2. **Decide on $0 renewal_revenue** - Filter or include?
3. **Decide on open deal treatment** - Denominator inclusion?

### If Variance Is Real

- ✅ Formula is working correctly
- ✅ Document as known business pattern
- ✅ Production-ready with current implementation

### If Variance Suggests Contamination

- 🔧 Add filter for $0 renewal_revenue
- 🔧 Adjust denominator to exclude open deals
- 🔧 Re-run validation to verify stability
- 🔧 Add "provisional" flag when open deals present

### If Data Quality Issues Found

- 🔍 Investigate why deals have $0 renewal_revenue
- 🔍 Investigate why closed period deals still open
- 🔍 Consider data quality gate before computation

---

## File Artifacts

**Working scripts:**
- `scripts/grr_cohort_formula.py` - Production formula (Q2 validated)
- `scripts/complete_grr_validation.py` - All 3 checks

**Documentation:**
- `GRR_FINAL_STATUS.md` - What's proven vs. pending
- `GRR_PRODUCTION_READINESS.md` - Original 3-check plan
- `GRR_VALIDATION_COMPLETE.md` - This file

**Status:** Validation complete, awaiting Jeff's assessment on 4 specific questions.
